Evelyn Icasiano

Suggest Changes
Learn More
PURPOSE This phase I trial sought to evaluate the toxicity of and determine the maximum-tolerated dose (MTD) for the two-drug regimen doxorubicin and gemcitabine (AG) followed by the three-drug(More)
  • 1